FUNCTIONAL CHARACTERIZATION OF THE POXVIRAL RING PROTEIN
FUNCTIONAL CHARACTERIZATION OF THE POXVIRAL RING PROTEIN
批准号:
7715924
负责人:
Klaus J Fruh
金额:
$5.55万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2009-04-30
关键词:
AffectApoptosisComputer Retrieval of Information on Scientific Projects DatabaseFundingGoalsGrantIn VitroInfectionInstitutionMediatingMolecularMolecular WeightPoxviridaeProteinsProteomicsResearchResearch PersonnelResourcesSourceTestingUV inducedUbiquitinUbiquitin-Activating EnzymesUbiquitin-Conjugating EnzymesUbiquitinationUnited States National Institutes of HealthViralVirulence FactorsVirusVirus Diseasesin vivomacrophageubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The goal of this project is to identify the molecular function of the poxviral virulence factor p28. P28 was shown to be an essential factor for controlling viral infection of macrophages and the inability to infect macrophages in vitro correlated with spontaneous clearance of infections in vivo. There is also some evidence that P28 protects against virally induced and UV-induced apoptosis. Specific aim 1 of this project is to test the hypothesis that p28 protects macrophages from apoptosis. We have recently demonstrated that P28 is a RING-domain ubiquitin ligase since P28 mediates the formation of high molecular weight ubiquitinated products in the presence of ubiquitin-conjugating enzymes, ubiquitin and the ubiquitin activating enzyme E1. In addition, we observed that ubiquitin is concentrated in poxvirus factories in the presence of P28 suggesting that P28 mediates the ubiquitination of viral and/or cellular proteins in virus factories. Therefore, Specific aim 2 is to use a proteomics approach to identify potential targets that are directly or indirectly affected by P28.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Non-canonical epitope presentation and antigen processing by MHC-E
-
批准号:10801509
-
项目类别:
-
资助金额:$71.95万
-
财政年份:2023
-
负责人:Klaus J Fruh
-
依托单位:
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
-
批准号:9982274
-
项目类别:
-
资助金额:$74.78万
-
财政年份:2017
-
负责人:Klaus J Fruh
-
依托单位:
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
-
批准号:9238234
-
项目类别:
-
资助金额:$81.25万
-
财政年份:2017
-
负责人:Klaus J Fruh
-
依托单位:
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
-
批准号:9751633
-
项目类别:
-
资助金额:$76.1万
-
财政年份:2017
-
负责人:Klaus J Fruh
-
依托单位:
An Effector Memory T Cell-Inducing Subunit Vaccine against Malaria
-
批准号:8423271
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2013
-
负责人:Klaus J Fruh
-
依托单位:
An Effector Memory T Cell-Inducing Subunit Vaccine against Malaria
-
批准号:8607501
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2013
-
负责人:Klaus J Fruh
-
依托单位:
MECHANISMS OF IMMUNE VULNERABILITY OF THE ELDERLY TO THE WEST NILE VIRUS
-
批准号:8357751
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
EVASION OF ANTIGEN PRESENTATION BY RHESUS CYTOMEGALOVIRUS
-
批准号:8357750
-
项目类别:
-
资助金额:$9.74万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
MODULATION OF INNATE IMMUNE RESPONSES BY CYTOMEGALOVIRUS
-
批准号:8357775
-
项目类别:
-
资助金额:$38.95万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
Development and Analysis of Replication-Deficient CMV Vectors
-
批准号:8117930
-
项目类别:
-
资助金额:$43.54万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
Kianse Networks Controling Flavivirus Replication
-
批准号:8234067
-
项目类别:
-
资助金额:$64.83万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
MODULATION OF INNATE IMMUNE RESPONSES BY CYTOMEGALOVIRUS
-
批准号:8357877
-
项目类别:
-
资助金额:$19.49万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
MECHANISMS OF T CELL ESCAPE BY ORTHOPOXVIRUSES
-
批准号:8357776
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2011
-
负责人:Klaus J Fruh
-
依托单位:
MECHANISMS OF T CELL ESCAPE BY ORTHOPOXVIRUSES
-
批准号:8173246
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:Klaus J Fruh
-
依托单位:
KINASE NETWORKS CONTROLLING FLAVIVIRUS REPLICATION
-
批准号:8173290
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Klaus J Fruh
-
依托单位:
MODULATION OF INNATE IMMUNE RESPONSES BY CYTOMEGALOVIRUS
-
批准号:8173245
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:Klaus J Fruh
-
依托单位:
EVASION OF ANTIGEN PRESENTATION BY RHESUS CYTOMEGALOVIRUS
-
批准号:8173206
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:Klaus J Fruh
-
依托单位:
IMMUNE EVASION BY GAMMA 2 HERPESVIRUSES
-
批准号:8173205
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2010
-
负责人:Klaus J Fruh
-
依托单位:
Modulation of Innate Immune Responses by Cytomegalovirus
-
批准号:7934975
-
项目类别:
-
资助金额:$49.2万
-
财政年份:2009
-
负责人:Klaus J Fruh
-
依托单位:
MODULATION OF INNATE IMMUNE RESPONSES BY CYTOMEGALOVIRUS
-
批准号:7958507
-
项目类别:
-
资助金额:$8.03万
-
财政年份:2009
-
负责人:Klaus J Fruh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: